CANADA LIFE ASSURANCE Co increased its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 2.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,366,977 shares of the real estate investment trust's stock after buying an additional 27,644 shares during the period. CANADA LIFE ASSURANCE Co owned about 0.20% of Healthpeak Properties worth $27,712,000 at the end of the most recent quarter.
A number of other hedge funds also recently added to or reduced their stakes in the business. Long Pond Capital LP bought a new position in Healthpeak Properties in the fourth quarter worth approximately $86,885,000. Zacks Investment Management raised its position in shares of Healthpeak Properties by 6.4% in the 4th quarter. Zacks Investment Management now owns 1,427,638 shares of the real estate investment trust's stock worth $28,938,000 after acquiring an additional 86,501 shares in the last quarter. NewEdge Advisors LLC lifted its stake in shares of Healthpeak Properties by 10.5% during the 4th quarter. NewEdge Advisors LLC now owns 14,409 shares of the real estate investment trust's stock worth $292,000 after purchasing an additional 1,371 shares during the last quarter. Insigneo Advisory Services LLC grew its stake in Healthpeak Properties by 9.5% in the fourth quarter. Insigneo Advisory Services LLC now owns 15,455 shares of the real estate investment trust's stock valued at $313,000 after purchasing an additional 1,339 shares during the last quarter. Finally, United Capital Financial Advisors LLC raised its holdings in Healthpeak Properties by 4.5% in the fourth quarter. United Capital Financial Advisors LLC now owns 63,953 shares of the real estate investment trust's stock worth $1,296,000 after purchasing an additional 2,769 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.
Healthpeak Properties Price Performance
NYSE DOC traded down $0.98 during trading hours on Friday, reaching $17.84. The company's stock had a trading volume of 5,438,775 shares, compared to its average volume of 4,899,643. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. Healthpeak Properties, Inc. has a 1-year low of $17.33 and a 1-year high of $23.26. The company's 50-day moving average is $19.60 and its two-hundred day moving average is $20.60. The firm has a market capitalization of $12.48 billion, a price-to-earnings ratio of 50.90, a P/E/G ratio of 2.17 and a beta of 1.02.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.46. The firm had revenue of $702.89 million for the quarter, compared to analysts' expectations of $690.76 million. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. On average, equities analysts predict that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.
Healthpeak Properties Announces Dividend
The company also recently declared a dividend, which will be paid on Wednesday, April 30th. Investors of record on Friday, April 18th will be given a dividend of $0.1017 per share. This represents a dividend yield of 6.5%. The ex-dividend date of this dividend is Thursday, April 17th. Healthpeak Properties's payout ratio is 348.57%.
Wall Street Analyst Weigh In
DOC has been the subject of several recent analyst reports. Scotiabank reduced their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a research note on Friday, February 28th. Wedbush reiterated an "outperform" rating and set a $24.00 price objective on shares of Healthpeak Properties in a report on Friday, April 11th. Robert W. Baird dropped their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a research note on Tuesday, February 11th. StockNews.com cut Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Wednesday. Finally, Morgan Stanley raised Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target for the company in a report on Wednesday, January 15th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $23.83.
Check Out Our Latest Analysis on Healthpeak Properties
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
